CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, NDC 83851-100-30. Manufactured by Wizcure Pharmaa PVT. LTD, H-681, Phase 3, RIICO Industrial Area, Bhiwadi- 301019 INDIA, Vistamerica USA, 20 Perkins Dr. Prescott, AZ 86301, Vistamerica USA, Made in India,

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    All lots
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Wizcure Pharmaa Private Limited
Reason for Recall:
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
ongoing

Product Information

Full Description:

CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, NDC 83851-100-30. Manufactured by Wizcure Pharmaa PVT. LTD, H-681, Phase 3, RIICO Industrial Area, Bhiwadi- 301019 INDIA, Vistamerica USA, 20 Perkins Dr. Prescott, AZ 86301, Vistamerica USA, Made in India,

Product Codes/Lot Numbers:

All lots

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0350-2026

Related Recalls

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Dec 31, 2025 Other Drugs Nationwide View Details →

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Dec 31, 2025 Other Drugs Nationwide View Details →

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Dec 31, 2025 Compounded Drugs Nationwide View Details →